search
Back to results

Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture

Primary Purpose

Proximal Femur Fracture

Status
Not yet recruiting
Phase
Phase 4
Locations
Czechia
Study Type
Interventional
Intervention
Intrathecal morphine administration
Parenteral administration of analgesics
Sponsored by
University Hospital Ostrava
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Proximal Femur Fracture focused on measuring proximal femur fracture, morphine administration, pain relief, intrathecal administration, parenteral administration, surgery

Eligibility Criteria

60 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: signed informed consent 60 to 90 years of age surgical treatment of proximal femur fracture The American Society of Anesthesiologists (ASA) classification I to III spinal anesthesia used for the operation Exclusion Criteria: general anesthesia used for the operation allergy to opioids high risk of respiratory depression

Sites / Locations

  • University Hospital Ostrava

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intrathecal morphine administration

Parenteral administration of analgesics

Arm Description

Study subjects randomized into this arm will be administered morphine intrathecally in the dose of dose 100 ug.

Study subjects randomized into this arm will receive standard postoperative pain management (parenteral administration of analgesics).

Outcomes

Primary Outcome Measures

Pain assessment
Pain intensity will be assessed using the Visual Analogue Scale (VAS10) scale (0-10). The total value of all measured values will be calculated. The maximum value observed during the 24 hours will be also recorded.
Pain assessment during patient positioning
Pain intensity will be assessed using the VAS10 scale (0-10) during the positioning of the patient.
Time to administration of rescue medication
The time to administration of rescue medication (analgesics) will be observed in hours.
Total consumption of opioids on Intensive Care Unit
The total consumption of opioids on Intensive Care Unit will be measured in the number of administered doses.

Secondary Outcome Measures

Hypoventilation - bradypnea
The observed parameters of hypoventilation include bradypnea = respiratory rate (RR)<10/min
Hypoventilation - presence of hypopnea (TV < 4)
The observed parameters of hypoventilation will include hypopnea = Tidal Volume (TV) < 4 ml/min. It is a physiological parameter that fluctuates depending on the load in the range of 6-180 liters/min.
Hypoventilation - SpO2
The observed parameters of hypoventilation will include inability to maintain oxygen saturation (SpO2) above 90 % without the need for oxygenotherapy.
Hypoventilation - presence of hypoxemia (paO2) (below 10 kPa)
The observed parameters of hypoventilation will include hypoxemia according to the analysis of blood gasses. Hypoxemia is diagnosed when the partial pressure of oxygen in the arterial blood (paO2) falls below 10 kiloPascals (kPa).
Hypoventilation - other signs of respiratory insufficiency
The observed parameters of hypoventilation will include other signs of respiratory insufficiency. Will be evaluated as 0-no, 1-yes + the need for oxygenotherapy, 2-yes+ the need for antidote or other treatment
Hypotension
The observed parameters of hypotension will be as follows: systolic blood pressure (SBP) < 90 mmHg and/or mean arterial pressure (MAP) < 60 mmHg and/or decrease of blood pressure (BP) by more than 20-30 % of the initial values. Evaluation: 0-no, 1-yes, without administration of noradrenaline, 2-yes, with noradrenaline administration.
Bradycardia
The observed parameters of bradycardia will be as follows: heart rate (HR) < 50/min. Evaluation: 0-no, 1-yes + administration of atropine or ephedrine, 2-yes+ administration of atropine repeatedly or other treatment.
Postoperative nausea and vomiting
The incidence of postoperative and vomiting will be observed. Evaluation: 0-no, 1-nausea, 2-vomiting
Effect of antiemetics
The effect of antiemetics will be observed. Evaluation: 0-not administered, 1-administered, 2-no effect
Pruritus
The presence and condition of pruritus will be observed. Evaluation: 0-no, 1-yes, no scratching, 2-moderate, need of scratching, 3-strong, need of treatment.
Effect of pruritus treatment
The effect of pruritus treatment will be observed. Evaluation: 0-no medication administered, 1-administered, 2-no effect

Full Information

First Posted
June 7, 2023
Last Updated
August 21, 2023
Sponsor
University Hospital Ostrava
search

1. Study Identification

Unique Protocol Identification Number
NCT05920642
Brief Title
Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture
Official Title
Risk-benefit Analysis of Intrathecal Morphine Administration to Patients Undergoing Surgical Treatment of Proximal Femoral Fracture (Monocentric, Single-blinded, Randomized Clinical Study Compared to Standard Treatment)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
September 4, 2023 (Anticipated)
Primary Completion Date
June 2025 (Anticipated)
Study Completion Date
June 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital Ostrava

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the study is to investigate postoperative pain relief for patients undergoing surgical treatment of proximal femoral fracture using intrathecal administration of morphine.
Detailed Description
In this study, the investigators will compare the efficiency of intrathecal morphine administration with the standard of care (parenteral application of analgesics) for pain relief in patients after proximal femoral fracture surgery. The secondary outcome measure will be to determine the frequency of adverse effects of intrathecally administered morphine. The study will be monocentric, randomized, and single-blinded. A total of 50 patients are expected to be enrolled.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Proximal Femur Fracture
Keywords
proximal femur fracture, morphine administration, pain relief, intrathecal administration, parenteral administration, surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
The study subjects will be randomized into two parallel groups.
Masking
Participant
Masking Description
The participant will not know which arm of the study he/she has been enrolled into.
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intrathecal morphine administration
Arm Type
Experimental
Arm Description
Study subjects randomized into this arm will be administered morphine intrathecally in the dose of dose 100 ug.
Arm Title
Parenteral administration of analgesics
Arm Type
Active Comparator
Arm Description
Study subjects randomized into this arm will receive standard postoperative pain management (parenteral administration of analgesics).
Intervention Type
Drug
Intervention Name(s)
Intrathecal morphine administration
Intervention Description
Administration of morphine into the spinal canal.
Intervention Type
Drug
Intervention Name(s)
Parenteral administration of analgesics
Intervention Description
Standard postoperative pain management of analgesics using parenteral route of administration.
Primary Outcome Measure Information:
Title
Pain assessment
Description
Pain intensity will be assessed using the Visual Analogue Scale (VAS10) scale (0-10). The total value of all measured values will be calculated. The maximum value observed during the 24 hours will be also recorded.
Time Frame
Every 2 hours after the surgery, total of 24 hours
Title
Pain assessment during patient positioning
Description
Pain intensity will be assessed using the VAS10 scale (0-10) during the positioning of the patient.
Time Frame
24 hours
Title
Time to administration of rescue medication
Description
The time to administration of rescue medication (analgesics) will be observed in hours.
Time Frame
24 hours
Title
Total consumption of opioids on Intensive Care Unit
Description
The total consumption of opioids on Intensive Care Unit will be measured in the number of administered doses.
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Hypoventilation - bradypnea
Description
The observed parameters of hypoventilation include bradypnea = respiratory rate (RR)<10/min
Time Frame
24 hours
Title
Hypoventilation - presence of hypopnea (TV < 4)
Description
The observed parameters of hypoventilation will include hypopnea = Tidal Volume (TV) < 4 ml/min. It is a physiological parameter that fluctuates depending on the load in the range of 6-180 liters/min.
Time Frame
24 hours
Title
Hypoventilation - SpO2
Description
The observed parameters of hypoventilation will include inability to maintain oxygen saturation (SpO2) above 90 % without the need for oxygenotherapy.
Time Frame
24 hours
Title
Hypoventilation - presence of hypoxemia (paO2) (below 10 kPa)
Description
The observed parameters of hypoventilation will include hypoxemia according to the analysis of blood gasses. Hypoxemia is diagnosed when the partial pressure of oxygen in the arterial blood (paO2) falls below 10 kiloPascals (kPa).
Time Frame
24 hours
Title
Hypoventilation - other signs of respiratory insufficiency
Description
The observed parameters of hypoventilation will include other signs of respiratory insufficiency. Will be evaluated as 0-no, 1-yes + the need for oxygenotherapy, 2-yes+ the need for antidote or other treatment
Time Frame
24 hours
Title
Hypotension
Description
The observed parameters of hypotension will be as follows: systolic blood pressure (SBP) < 90 mmHg and/or mean arterial pressure (MAP) < 60 mmHg and/or decrease of blood pressure (BP) by more than 20-30 % of the initial values. Evaluation: 0-no, 1-yes, without administration of noradrenaline, 2-yes, with noradrenaline administration.
Time Frame
24 hours
Title
Bradycardia
Description
The observed parameters of bradycardia will be as follows: heart rate (HR) < 50/min. Evaluation: 0-no, 1-yes + administration of atropine or ephedrine, 2-yes+ administration of atropine repeatedly or other treatment.
Time Frame
24 hours
Title
Postoperative nausea and vomiting
Description
The incidence of postoperative and vomiting will be observed. Evaluation: 0-no, 1-nausea, 2-vomiting
Time Frame
24 hours
Title
Effect of antiemetics
Description
The effect of antiemetics will be observed. Evaluation: 0-not administered, 1-administered, 2-no effect
Time Frame
24 hours
Title
Pruritus
Description
The presence and condition of pruritus will be observed. Evaluation: 0-no, 1-yes, no scratching, 2-moderate, need of scratching, 3-strong, need of treatment.
Time Frame
24 hours
Title
Effect of pruritus treatment
Description
The effect of pruritus treatment will be observed. Evaluation: 0-no medication administered, 1-administered, 2-no effect
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: signed informed consent 60 to 90 years of age surgical treatment of proximal femur fracture The American Society of Anesthesiologists (ASA) classification I to III spinal anesthesia used for the operation Exclusion Criteria: general anesthesia used for the operation allergy to opioids high risk of respiratory depression
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jiří Hynčica
Phone
0042059737
Ext
2587
Email
jiri.hyncica@fno.cz
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Denis Buršík, MD
Organizational Affiliation
University Hospital Ostrava
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Ostrava
City
Ostrava
State/Province
Moravian-Silesian Region
ZIP/Postal Code
70852
Country
Czechia
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jiří Hynčica
Phone
0042059737
Ext
2587
Email
jiri.hyncica@fno.cz
First Name & Middle Initial & Last Name & Degree
Denis Buršík, MD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is no plan to make the individual participant data public.
Citations:
PubMed Identifier
14570664
Citation
Rathmell JP, Pino CA, Taylor R, Patrin T, Viani BA. Intrathecal morphine for postoperative analgesia: a randomized, controlled, dose-ranging study after hip and knee arthroplasty. Anesth Analg. 2003 Nov;97(5):1452-1457. doi: 10.1213/01.ANE.0000083374.44039.9E.
Results Reference
background
PubMed Identifier
19921358
Citation
Yamashita K, Fukusaki M, Ando Y, Tanabe T, Terao Y, Sumikawa K. Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients. J Anesth. 2009;23(4):504-7. doi: 10.1007/s00540-009-0817-5. Epub 2009 Nov 18.
Results Reference
background
PubMed Identifier
11847368
Citation
Kwan AS, Lee BB, Brake T. Intrathecal morphine for post-operative analgesia in patients with fractured hips. Hong Kong Med J. 1997 Sep;3(3):250-255.
Results Reference
background

Learn more about this trial

Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture

We'll reach out to this number within 24 hrs